Lenirit Dermatological Cream 0.5% Hydrocortisone Acetate 20g

Lenirit Dermatological Cream 0.5% Hydrocortisone Acetate 20g

EG

SKU
025869013
Special Price €8.34 Regular Price €11.50 Save... €3.16 -27%
Recent lowest price:   €8.20
In stock
icomoon-up
icomoon-down
NAME
LENIRIT 0.5% CREAM

PHARMACOTHERAPEUTIC CATEGORY
Corticosteroids, not associated.

ACTIVE PRINCIPLES
Hydrocortisone acetate 0.5 g.

EXCIPIENTS
Polyglycol ester of C12-C18 fatty acids; self-emulsifying glyceryl monodistearate; squalane; cetyl palmitate; methyl parahydroxybenzoate; ethyl parahydroxybenzoate; propyl parahydroxybenzoate; perfume; purified water.

INDICATIONS
Insect bites, itching, localized rashes or burns, eczema.

CONTRAINDICATIONS / SECONDARY EFFECT
Known hypersensitivity to the active substance or to any of the excipients. Infections and skin diseases: tuberculosis, pyoderma, mycosis, as well as skin ulcers and wounds, skin cancers. The use of the cream is contraindicated on the skin of the face, on the anogenital area, on large lesions, infectious diseases (syphilis), viral infectious diseases (such as herpes, chicken pox), perioral dermatitis, acne, acne rosacea, skin reactions after a vaccination, pustular psoriasis. The medicine should not be used in infants and children under 2 years of age '.

DOSAGE
Rubbing lightly, spread the cream on the affected part in a thin layer, twice a day. Do not exceed the recommended dose. The medicine should not be used in children younger 'less than two years.

STORAGE
This medicine does not require any special storage conditions.

WARNINGS
If conditions worsen or if symptoms persist for more than 7 days, discontinue applications and consult a doctor. Avoid contact with eyes. The use, especially if prolonged, of topical medicines can give rise to irritation or sensitization phenomena. In this case it is necessary to interrupt the treatment and institute a suitable therapy. Prolonged use of this medicine can cause telangiectasia and skin atrophy. When used for a long time, or on a large area of skin, hydrocortisone can be absorbed into the blood and exert systemic activity. This occurrence occurs more easily if the occlusive bandage is used; the diaper can act as an occlusive dressing. Systemic absorption of topical corticosteroids can lead to reversible suppression of the hypothalamus-pituitary-adrenal axis with potential glucocorticosteroid insufficiency after discontinuation of treatment. As a result of systemic absorption of topical corticosteroids, manifestations of Cushing's syndrome, glycosuria, hyperglycaemia may also occur in some patients during treatment. Patients applying a topical steroid over a large surface or in areas with occlusive dressing should be monitored periodically for suppression of the hypothalamus-pituitary-adrenal axis. In case of use in the area adjacent to the eyes, appropriate precautions should be taken, as the penetration of the medicine into the eyes can cause glaucoma or cataracts. If this happens, the cream residue should be rinsed off with water. The cream contains ethyl parahydroxybenzoate, methyl parahydroxybenzoate and propyl parahydroxybenzoate which can cause allergic reactions (including delayed). Pediatric population: do not use in infants and children under 2 years' diet. Particular caution is recommended when using the medicinal product in children due to the risk of systemic exposure to hydrocortisone. Because the body surface area to body weight ratio in children is higher than in adults, children are at greater risk of systemic corticosteroid effects, including hypothalamic-pituitary-adrenal axis suppression and Cushing's syndrome, than adults. Prolonged use of corticosteroids in children can cause growth and developmental disturbances. The duration of treatment should be as short as possible and the lowest dose should be used. The growth and development of the child should be monitored. Use in elderly patients: elderly people may experience more marked undesirable effects, especially in cases of co-morbidities, such as osteoporosis, hypertension, hypokalaemia, diabetes mellitus, in addition to greater susceptibility to infections and a reduction in skin thickness. These people must be carefully monitored to avoid the occurrence of life-threatening reactions. In case of subcutaneous atrophic conditions, especially in the elderly, the medicinal product should be used with caution. Use in patients with renal or hepatic insufficiency: in patients with hepatic disease or renal insufficiency special precautions should be used for use and frequent clinical monitoring of the state of health is necessary.

INTERACTIONS
No cases of interaction and incompatibility with other medicinal products have been reported.

SIDE EFFECTS
The use, especially if prolonged, of products for topical use can give rise to phenomena of irritation or sensitization. In this case it is necessary to interrupt the treatment and institute a suitable therapy.During the application of the cream, acne, steroid-induced purpura, dry skin, hypertrichosis, hypopigmentation of the skin, skin atrophy and striae, telangiectasia, perioral dermatitis, folliculitis, pruritus may occur. . The increased absorption due to the use of an occlusive dressing can cause systemic effects such as edema, hypertension and impaired immune system; Suppression of the hypothalamic-pituitary-adrenal axis and Cushing's syndrome may also occur, particularly in pediatric patients. Prolonged use of corticosteroids in children can cause growth and developmental disturbances. Glaucoma or cataracts may occasionally occur following topical application to the eyelid area. The incidence of adverse reactions is not known. The reporting of suspected adverse reactions that occur after the authorization of the drug is important, as it allows continuous monitoring of the benefit / risk ratio of the drug.

PREGNANCY AND BREASTFEEDING
The use of the medicine is not recommended during pregnancy and lactation.
Destination Cost Detail
Italy €5,90 24/48 h
Austria, Belgium, France, Germany, Netherlands, Poland, Czech Republic € 12* 3 days
Denmark,Luxembourg,Portugal,Slovakia,Spain,Hungary € 16* 4 days
Bulgary,Croatia,Estonia,Finland,Greece,Ireland,Lithuania,Romania,Slovenia,Sweden € 27* 5 days
Canada, Switzerland, United Kingdom, USA € 45 7 Days

National shipments with express courier: Bartolini, GLS
European shipments with express courier: FedEx, MBE, DHL
*For the shipment outside band B ther's an extra cost of 20€
*For the shipment outside band C ther's an extra cost of 30€
Delivery Times exclude Saturday and Holidays
For Islands and Areas of difficult Accessibility the shipments are made in 72 hours and the cost will be increased by 15€
The images of the products shown on our site are purely indicative and may differ in shape, color, text and packaging shown on them. Given the difficulty of updating all the products on our site in real time or any errors, XFarma.it, all products will be identified through SKU MINSAN (code of the Ministry of Health).